|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023981,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0036581,
umls-concept:C0036983,
umls-concept:C0085559,
umls-concept:C0205082,
umls-concept:C0242966,
umls-concept:C1274040,
umls-concept:C1883163,
umls-concept:C2603343
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-1-1
|
|
pubmed:abstractText |
Sepsis is associated with an increase in reactive oxygen species and low endogenous antioxidative capacity. We postulated that high-dose supplementation of sodium-selenite would improve the outcome of patients with severe sepsis and septic shock.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0090-3493
|
|
pubmed:author |
pubmed-author:AbelPeterP,
pubmed-author:AngstwurmMatthias W AMW,
pubmed-author:EngelmannLotharL,
pubmed-author:GärtnerRolandR,
pubmed-author:InselRudolfR,
pubmed-author:LehmannChristianC,
pubmed-author:Meier-HellmannAndreasA,
pubmed-author:RadkeJoachimJ,
pubmed-author:SchüttlerJürgenJ,
pubmed-author:SpesChristoph HCH,
pubmed-author:StraussRichardR,
pubmed-author:ZimmermannThomasT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
118-26
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17095947-APACHE,
pubmed-meshheading:17095947-Adult,
pubmed-meshheading:17095947-Aged,
pubmed-meshheading:17095947-Aged, 80 and over,
pubmed-meshheading:17095947-Disseminated Intravascular Coagulation,
pubmed-meshheading:17095947-Double-Blind Method,
pubmed-meshheading:17095947-Drug Monitoring,
pubmed-meshheading:17095947-Female,
pubmed-meshheading:17095947-Germany,
pubmed-meshheading:17095947-Glutathione Peroxidase,
pubmed-meshheading:17095947-Hospital Mortality,
pubmed-meshheading:17095947-Humans,
pubmed-meshheading:17095947-Infusions, Intravenous,
pubmed-meshheading:17095947-Kaplan-Meier Estimate,
pubmed-meshheading:17095947-Male,
pubmed-meshheading:17095947-Middle Aged,
pubmed-meshheading:17095947-Multiple Organ Failure,
pubmed-meshheading:17095947-Prospective Studies,
pubmed-meshheading:17095947-Sepsis,
pubmed-meshheading:17095947-Severity of Illness Index,
pubmed-meshheading:17095947-Shock, Septic,
pubmed-meshheading:17095947-Sodium Selenite,
pubmed-meshheading:17095947-Survival Rate,
pubmed-meshheading:17095947-Systemic Inflammatory Response Syndrome,
pubmed-meshheading:17095947-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
|
|
pubmed:affiliation |
Medizinische Klinik Innenstadt, Ludwig-Maximilians Universität München, Münich, Germany.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|
